At Pfizer David worked on a number of multi-million dollar in-licensing deals, drafted and negotiated agreements in support of Pfizer’s research and development activities, acted as lead counsel for Pfizer’s biotherapeutics program and the Pain Therapeutic Area and was the legal site head for Pfizer’s Michigan Laboratories.

Before joining Pfizer, David was in-house counsel with Esperion Therapeutics, a small biotherapeutic discovery and development company later acquired by Pfizer. At Esperion David handled all of Esperion’s day to day transactional matters, assisted in the preparation of Esperion’s SEC filings, managed litigation, was a member of the business development team and was co-chair of Esperion’s lead development program.

David has lectured at the University of Michigan on various topics including historical perspectives on human subject research, and also serves as a moot court judge at the University of Michigan Law School.

David holds a law degree from George Washington University, Washington, D.C., and a MUP and BA from the University of Michigan.